2 recruiting, 1 active not recruiting. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Cardiopulmonary Stress Test: new trials by email Literature Review of Cardiopulmonary Stress Test trials Research Report on Cardiopulmonary Stress Test
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dissolved Phase HXe-129 MRI: A Novel Biomarker to Quantify Pulmonary Pathology Hyperpolarized xenon 129, Cardiopulmonary Stress Test, Pulmonary Function Test - Electronic Cigarette Related Lung Damage | Phase 2 / Phase 3 | Recruiting | Y. Michael Shim, MD | 80 | 2024-12-19 | 2026-03-17 |
| Radiotherapy Exposed Lung Injury: Effect on Functioning - Cohort Radiation therapy protocol for Breast cancer, Spirography and assessment of pulmonary diffusion capacity, Cardiopulmonary stress test - Breast Neoplasms, Radiation Pneumonia | Recruiting | Meshalkin Research Institute of Pathology of Circulation | 200 | 2023-07-18 | 2025-02-11 | |
| State of Oxygen Metabolism, Cardiovascular and Respiratory System Reserve Capacity in Patients Who Underwent COVID-19 Spirography and assessment of pulmonary diffusion capacity, Cardiopulmonary stress test, Computed tomography of the chest organs - Covid19, COVID19 Infection | Active not recruiting | Meshalkin Research Institute of Pathology of Circulation | 100 | 2020-08-25 | 2025-02-11 |
Breast Neoplasms (1) · COVID-19 (1) · Radiation Fibrosis Syndrome (1) · Radiation Pneumonitis (1) · Vaping (1)
Meshalkin Research Institute of Pathology of Circulation (2) · Y. Michael Shim, MD (1)
Russia (2) · United States (1)
Oksana Kamenskaya, PhD, MD (2) · Yun M Shim, MD (1)